HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by SORBE, B. Articles by FRANKENDAL, B. Search for Related Content PubMed PubMed Citation Articles by SORBE, B. Articles by FRANKENDAL, B.

Bleomycin-Adriamycin-Cisplatin Combination Chemotherapy in the Treatment of Primary Advanced and Recurrent Cervical Carcinoma

From the Department of Gynecologic Oncology, Regionsjukhuset, S-701 85 Örebro, Sweden

Abstract

A chemotherapeutic combination of bleomycin-adriamycincisplatin has been used to treat 21 consecutive patients with primary advanced or recurrent cervical carcinomas. Four complete (19.0%) and four partial remissions were recorded. The responding patients had significantly longer survival levels compared with the remaining 13 with stable disease. No patient had progressive disease during treatment. The median survival of the complete series was 9.2 months. The objective response rate was 14.3% for tumors within previously irradiated pelvic tissues but 100% (75.0% complete remissions) for distant metastases. Anemia, anorexia, and progressive weakness were troublesome side effects, however, and they seriously limited the clinical usefulness of this bleomycin-adriamycin-cisplatin regimen in the treatment of primary advanced and recurrent cervical carcinomas.